PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

ICU Meningitis and Encephalitis: Time-Critical Antimicrobials and ICP Control

vancomycinceftriaxonecefotaximeampicillinacyclovirdexamethasonemannitolhypertonic salinebacterial meningitisviral encephalitistuberculous meningitiscryptococcal meningitisintracranial pressureCSF diversionneurocritical carenarrative reviewantimicrobial timing Critical Care / ICU

Background Information

Swift ICU action saves lives in meningitis cases.

Meningitis and encephalitis require urgent ICU management due to potential severe complications. Early antimicrobial treatment with optional adjuvant steroids improves outcomes; manage seizures, intracranial pressure, and potential neurosurgical needs. Ensures ICU teams prioritize quick diagnosis, appropriate interventions, and manage complications effectively. Swift, targeted ICU interventions can save lives in meningitis and encephalitis cases.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Marquez D, Dangayach NS

Citation: Marquez D, Dangayach NS Intensive Care Unit Management of Meningitis and Encephalitis. Critical care clinics. 2026;42(3):481-498. doi:10.1016/j.ccc.2026.01.006

Article Links: PubMed · Journal / DOI

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.